Quantcast

Latest short bowel syndrome Stories

2014-09-23 04:21:56

OxThera AB announced today that its product Oxabact® has been granted an Orphan Drug Designation in the European Union for treatment of Short Bowel Syndrome (SBS) STOCKHOLM, September 23, 2014 /PRNewswire/ -- SBS is a highly disabling malabsorptive condition. SBS is associated with significant morbidity and mortality, reduced quality of life and high healthcare costs. "We are happy to announce that Oxabact(R) is now also recognized as a potential treatment for Short...

2013-12-09 23:02:16

IT GUTS BETTER, will officially kick-off on Tuesday, December 10, 2013. The project was created and founded by Metro Maryland Ostomy Association President, Scott Bowling. Rockville, MD (PRWEB) December 09, 2013 Metro Maryland Ostomy Association, In c., a Rockville, MD based non-profit organization housed in the Non-Profit Village of Montgomery County is pleased to announce the launch of its 40th Anniversary celebration in concert with its new Flagship Project "IT GUTS BETTER"....

2011-05-11 00:22:46

Health outcomes explored at DDW 2011 Research being presented at Digestive Disease Week® (DDW) shows that patients taking a blood thinner (clopidogrel) after having polyps removed during colonoscopy were at relatively low risk of bleeding. Another study shows that a new drug that acts as a hormone, teduglutide, increases intestinal absorption for individuals with short bowel syndrome, which may decrease dependence on intravenous fluid and nutritional support in this at-risk...

2010-09-22 08:00:00

DETROIT, Sept. 22 /PRNewswire/ -- The first intestine (bowel) transplant in Michigan was performed on a 50-year-old patient from Port Austin by physicians at Henry Ford Hospital. The 11-hour surgery was performed on August 21 and 22. The composite multivisceral transplant procedure included transplant of the patient's small bowel, stomach and pancreas. Only a few centers in the United States offer intestine transplants and Henry Ford is the only one in Michigan with a program. The...

2010-05-07 09:42:33

Young people with inflammatory bowel diseases have low bone mass and poor bone architecture compared to healthy people of the same age, placing them at increased risk of fracture A team of scientists from the University Hospitals of Geneva and Lausanne have shown that young people with inflammatory bowel diseases have low bone mass and poor bone architecture compared to healthy people of the same age, placing them at increased risk of fracture. Inflammatory bowel disease is a general term...

2008-10-15 18:00:08

NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) today announced that four abstracts summarizing data from the Company's Phase 3 studies of GATTEX(TM) (teduglutide) in patients with short bowel syndrome (SBS) were selected for oral presentations at the 16th United European Gastroenterology Week (UEGW) meeting in Vienna, Austria, October 18-22, 2008, including a presentation of 52-week data from the Phase 3 study of GATTEX in SBS patients. The UEGW is the largest gastroenterology meeting in Europe....

2008-10-08 12:00:08

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) today presented positive one-year data from a Phase 3-extension study of GATTEX(TM) (teduglutide), an investigational product for patients dependent upon parenteral nutrition due to short bowel syndrome (SBS). SBS is primarily caused by intestinal resection and the subsequent inability to maintain oral fluid, electrolyte, and nutrient balances. The results showed GATTEX was well tolerated out to one year and provided the ability to safely reduce...

2008-09-25 15:00:00

NPS Pharmaceuticals, Inc. Susan Mesco, 908-450-5516 smesco@npsp.com Logo: http://www.npsp.com NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) today reported that three abstracts summarizing data from the company's Phase 3 studies of GATTEX(TM) (teduglutide) in patients with short bowel syndrome (SBS) were accepted for presentation at the American College of Gastroenterology (ACG) Annual Scientific Meeting and Postgraduate Course in Orlando, Florida, October 3-8, 2008, including an oral...

2008-09-11 18:00:09

NPS Pharmaceuticals (Nasdaq: NPSP) today reported that data from clinical studies of GATTEX(TM) (teduglutide) in intestinal failure associated with short bowel syndrome will be presented at upcoming medical meetings. At the 30th Congress of the European Society for Clinical Nutrition and Metabolism (ESPEN) taking place in Florence, Italy September 13-16, 2008 clinical data from a 24-week Phase 3 study of GATTEX for short bowel syndrome (SBS) patients who are dependent upon parenteral...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.